Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Guido

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Translational Gastroenterology and Hepatology|August 28, 2018
Precision medicine in cholangiocarcinomaAntonio Pellino, Fotios Loupakis, Massimiliano Cadamuro, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal studyFlavia Bortolotti, Maria Guido, Samuela Bartolacci, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2021
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosisNora Cazzagon, Samantha Sarcognato, Annarosa Floreani, et al.
Endocrine Pathology|November 18, 2019
Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic MutationsValeria Maffeis, Rocco Cappellesso, Lorenzo Nicolè, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis CMoira Marcolongo, Bradford Young, Francesca Dal Pero, et al.
JHEP Reports : Innovation in Hepatology|May 3, 2024
Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinomaTimothy Kendall, Diletta Overi, Maria Guido, et al.
Hepatology International|July 24, 2015
Circulating free DNA in the progression of liver damage to hepatocellular carcinomaMarika Piciocchi, Romilda Cardin, Alessandro Vitale, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 16, 2005
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overloadAnnarosa Floreani, Filippo Navaglia, Daniela Basso, et al.
Pathologica|July 23, 2021
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitisSamantha Sarcognato, Diana Sacchi, Federica Grillo, et al.
Biology|May 28, 2022
The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLDDaniela Gabbia, Marco Roverso, Samantha Sarcognato, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Translational Gastroenterology and Hepatology|August 28, 2018
Precision medicine in cholangiocarcinomaAntonio Pellino, Fotios Loupakis, Massimiliano Cadamuro, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal studyFlavia Bortolotti, Maria Guido, Samuela Bartolacci, et al.
JHEP Reports : Innovation in Hepatology|May 27, 2021
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosisNora Cazzagon, Samantha Sarcognato, Annarosa Floreani, et al.
Endocrine Pathology|November 18, 2019
Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic MutationsValeria Maffeis, Rocco Cappellesso, Lorenzo Nicolè, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis CMoira Marcolongo, Bradford Young, Francesca Dal Pero, et al.
JHEP Reports : Innovation in Hepatology|May 3, 2024
Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinomaTimothy Kendall, Diletta Overi, Maria Guido, et al.
Hepatology International|July 24, 2015
Circulating free DNA in the progression of liver damage to hepatocellular carcinomaMarika Piciocchi, Romilda Cardin, Alessandro Vitale, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 16, 2005
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overloadAnnarosa Floreani, Filippo Navaglia, Daniela Basso, et al.
Pathologica|July 23, 2021
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitisSamantha Sarcognato, Diana Sacchi, Federica Grillo, et al.
Biology|May 28, 2022
The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLDDaniela Gabbia, Marco Roverso, Samantha Sarcognato, et al.
Pageof 14